Sinohealth Holdings (2361) Stock Overview
Provides healthcare solutions for sales and marketing needs of medical product manufacturer clients in Mainland China, the Netherland, England, Hong Kong, Singapore, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Risk Analysis
No risks detected for 2361 from our risk checks.
2361 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Sinohealth Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$5.00 |
| 52 Week High | HK$5.50 |
| 52 Week Low | HK$2.24 |
| Beta | -0.29 |
| 1 Month Change | 21.95% |
| 3 Month Change | 54.32% |
| 1 Year Change | 7.99% |
| 3 Year Change | 5.49% |
| 5 Year Change | n/a |
| Change since IPO | -6.72% |
Recent News & Updates
Sinohealth Holdings Limited's (HKG:2361) 25% Share Price Surge Not Quite Adding Up
Dec 03
Sinohealth Holdings (HKG:2361) Will Pay A Larger Dividend Than Last Year At CN¥0.12
Jun 18Recent updates
Sinohealth Holdings Limited's (HKG:2361) 25% Share Price Surge Not Quite Adding Up
Dec 03Sinohealth Holdings (HKG:2361) Will Pay A Larger Dividend Than Last Year At CN¥0.12
Jun 18Sinohealth Holdings (HKG:2361) Has Announced That It Will Be Increasing Its Dividend To CN¥0.12
Apr 24Sinohealth Holdings' (HKG:2361) Anemic Earnings Might Be Worse Than You Think
Sep 30Weak Statutory Earnings May Not Tell The Whole Story For Sinohealth Holdings (HKG:2361)
Apr 28Sinohealth Holdings Limited Just Recorded A 240% EPS Beat: Here's What Analysts Are Forecasting Next
Apr 02Shareholder Returns
| 2361 | HK Healthcare Services | HK Market | |
|---|---|---|---|
| 7D | 3.5% | -1.2% | -2.9% |
| 1Y | 8.0% | -0.7% | 27.0% |
Return vs Industry: 2361 exceeded the Hong Kong Healthcare Services industry which returned -0.7% over the past year.
Return vs Market: 2361 underperformed the Hong Kong Market which returned 27% over the past year.
Price Volatility
| 2361 volatility | |
|---|---|
| 2361 Average Weekly Movement | 4.0% |
| Healthcare Services Industry Average Movement | 4.9% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in HK Market | 14.5% |
| 10% least volatile stocks in HK Market | 3.0% |
Stable Share Price: 2361 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 2361's weekly volatility has decreased from 9% to 4% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 756 | Yushu Wu | ir.sinohealth.cn |
Sinohealth Holdings Limited provides healthcare solutions for sales and marketing needs of medical product manufacturer clients in Mainland China, the Netherland, England, Hong Kong, Singapore, and internationally. It engages in the research and development, and provision of data insight solutions, data-driven publications and events, and software as a service (SaaS) products; research and development, and operation of Smart Medical Cloud under the business line of SaaS products; management of marketing and promotion services of medicine; operation of SaaS products; provision of internet information and internet data center services; production and publication of videos; and foreign-related market research business. The company also offers precision marketing solutions; and consulting and marketing services.
Sinohealth Holdings Limited Fundamentals Summary
| 2361 fundamental statistics | |
|---|---|
| Market cap | HK$2.04b |
| Earnings (TTM) | HK$103.25m |
| Revenue (TTM) | HK$432.00m |
Is 2361 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2361 income statement (TTM) | |
|---|---|
| Revenue | CN¥392.12m |
| Cost of Revenue | CN¥165.61m |
| Gross Profit | CN¥226.52m |
| Other Expenses | CN¥132.80m |
| Earnings | CN¥93.72m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.23 |
| Gross Margin | 57.77% |
| Net Profit Margin | 23.90% |
| Debt/Equity Ratio | 0% |
How did 2361 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/10 22:22 |
| End of Day Share Price | 2025/12/10 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sinohealth Holdings Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kai Wang | Morningstar Inc. |